<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22930" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Neonatal HIV</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Abbas</surname>
            <given-names>Malak</given-names>
          </name>
          <aff>Corewell Health</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bakhtyar</surname>
            <given-names>Arsala</given-names>
          </name>
          <aff>Beaumont Health</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bazzi</surname>
            <given-names>Rima</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Malak Abbas declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Arsala Bakhtyar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rima Bazzi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>20</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22930.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Over 95% of HIV-infected pediatric cases are a result of vertical transmission. Neonatal HIV is the concern for HIV in an infant born to a mother with known or suspected HIV disease. It is important to identify those patients early so that appropriate treatment and monitoring can be implemented. This activity outlines the evaluation and management of neonatal HIV and reviews the interprofessional team's role in managing these patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the etiology and epidemiology of neonatal HIV.</p></list-item><list-item><p>Assess&#x000a0;the common presentation, history, and diagnosis of neonatal HIV.</p></list-item><list-item><p>Determine the appropriate treatment and management options available for neonatal HIV.</p></list-item><list-item><p>Determine interprofessional team strategies for improving care coordination and communication to advance the identification of those at risk for neonatal HIV and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22930&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22930">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-22930.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Over 95% of HIV-infected pediatric cases are a result of vertical transmission. The pathophysiology of the HIV disease state in the pediatric population is similar to adults. However, differences occur in the clinical presentation, mode of infection, and therapeutic options. The pediatric and neonatal populations have a weaker immune system than adults; therefore, if infected with HIV, they are at a greater risk of opportunistic infections. As such, the delay of treatment may result in a rapid progression of the disease.</p>
        <p>One of the greatest advancements in medicine has been the prevention of mother-to-child transmission (MTCT) of&#x000a0;HIV&#x000a0;type 1 (HIV-1). The rate of transmission of HIV to neonates has been reduced to less than 1% with the implementation of appropriate strategies and careful planning. The increase in comprehensive serologic screening and the treatment of HIV-infected pregnant females has resulted in the reduction of vertical transmission. There are evidence-based prevention modalities that can be utilized at different stages of pregnancy and postpartum to improve outcomes. Antiretroviral therapies (ART) can be prescribed during gestation, antepartum during vaginal or elective cesarean delivery, postnatally to the neonate, or when breastfeeding.<xref ref-type="bibr" rid="article-22930.r1">[1]</xref><xref ref-type="bibr" rid="article-22930.r2">[2]</xref></p>
      </sec>
      <sec id="article-22930.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>HIV&#x000a0;is a ribonucleic acid (RNA) viral pathogen with&#x000a0;2 subtypes: HIV-1 and HIV-2. HIV-1 is the most common type worldwide and is more transmissible and progresses faster than HIV-2. Presumably, this Retroviridae family originated from wild chimpanzees in Central Africa.<xref ref-type="bibr" rid="article-22930.r3">[3]</xref> The virus is transmitted across mucous membranes via penetrative unprotected sexual intercourse or intravenous drug use, blood transfusions in developing countries, vertical transmission, or through breastfeeding.<xref ref-type="bibr" rid="article-22930.r4">[4]</xref><xref ref-type="bibr" rid="article-22930.r5">[5]</xref> The risk of transmission via lactation is about 12-14%, with the risk increasing in high viral load states.<xref ref-type="bibr" rid="article-22930.r6">[6]</xref><xref ref-type="bibr" rid="article-22930.r7">[7]</xref> Overall, the probability of vertical transmission is about 25% without the utilization of appropriate ART therapy during pregnancy. Several risk factors that increase the chance of this transmission were observed in clinical trials. The risk factors include elevated maternal plasma viral RNA concentrations, maternal breast milk viral load, acute maternal seroconversion, advanced maternal disease, and decreased CD4+ T-cell count of the mother.<xref ref-type="bibr" rid="article-22930.r8">[8]</xref><xref ref-type="bibr" rid="article-22930.r9">[9]</xref><xref ref-type="bibr" rid="article-22930.r10">[10]</xref><xref ref-type="bibr" rid="article-22930.r11">[11]</xref><xref ref-type="bibr" rid="article-22930.r12">[12]</xref></p>
      </sec>
      <sec id="article-22930.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The burden of MTCT is a worldwide epidemic, with an estimated 160,000 infants infected annually with HIV as of 2018. The majority of mothers and neonates infected with HIV are located in sub-Saharan Africa.<xref ref-type="bibr" rid="article-22930.r13">[13]</xref> Overall, the rate of perinatal transmission of HIV has decreased substantially over the past 20 years to less than 1% in the United States and Europe.<xref ref-type="bibr" rid="article-22930.r14">[14]</xref><xref ref-type="bibr" rid="article-22930.r15">[15]</xref> In the United States, approximately more than 5,000 pregnant females are HIV positive.<xref ref-type="bibr" rid="article-22930.r16">[16]</xref>&#x000a0;In the year 2013, nationwide in the United States, there were only 69 infants born with HIV infection, leading to an estimated incidence of 1.8 out of 100,000 live births for perinatally-acquired HIV infection.<xref ref-type="bibr" rid="article-22930.r14">[14]</xref>&#x000a0;The Centers for Disease Control and Prevention (CDC) in the United States (US) has set goals to eliminate perinatal HIV spread, which has caused a significant decline in MTCT transmission. The goal is to reduce the incidence of perinatal HIV to less than 1 in 100,000 births.<xref ref-type="bibr" rid="article-22930.r14">[14]</xref> During the peak of HIV transmission in 1991, the reported incidence of neonates born with HIV was 42.8 per 100,000 births, with a substantial decline to 1.3 per 100,000 live-born infants in 2015.<xref ref-type="bibr" rid="article-22930.r17">[17]</xref> Due to racial disparities in healthcare, the incidence of perinatal HIV is 5 times greater in Black versus White infants.<xref ref-type="bibr" rid="article-22930.r18">[18]</xref></p>
      </sec>
      <sec id="article-22930.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The main target for HIV entry into the cells is through infection of cells expressing the CD4 receptor and chemokine receptors CCR5 and CXCR4.<xref ref-type="bibr" rid="article-22930.r19">[19]</xref> Additionally, the HIV virus infects dendritic cells, activated CD4 T-lymphocytes, monocytes, and macrophages.<xref ref-type="bibr" rid="article-22930.r20">[20]</xref>&#x000a0;The result is increased host susceptibility to diseases due to decreased immune-protective functions.&#x000a0;</p>
        <p>Infants with HIV-1 infections have higher viral loads and a faster progression to AIDS than adults with HIV.<xref ref-type="bibr" rid="article-22930.r21">[21]</xref><xref ref-type="bibr" rid="article-22930.r22">[22]</xref> The most common mode of transmission in a neonate with HIV is mother-to-child transmission (MTCT). The virus may be transmitted during different stages of pregnancy and postpartum, with the perinatal period as the most common transmission time.<xref ref-type="bibr" rid="article-22930.r23">[23]</xref></p>
        <p>
<bold>In-utero Transmission</bold>
</p>
        <p>The mechanism of in-utero transmission is predicted to be by transcytosis across placental cells. The placenta may also host the virus to replicate before moving to the fetus.<xref ref-type="bibr" rid="article-22930.r24">[24]</xref> The HIV-1 virus may also traverse the trophoblastic placental barrier via endocytosis, specifically crossing cytotrophoblasts or syncytiotrophoblasts within the uterine wall. HIV-1 may also spread to the fetus via villous capillaries. The risk of in-utero transmission increases with inflammation and infection of the placenta and amniotic membranes.<xref ref-type="bibr" rid="article-22930.r24">[24]</xref><xref ref-type="bibr" rid="article-22930.r25">[25]</xref><xref ref-type="bibr" rid="article-22930.r26">[26]</xref><xref ref-type="bibr" rid="article-22930.r27">[27]</xref><xref ref-type="bibr" rid="article-22930.r28">[28]</xref></p>
        <p>
<bold>Intrapartum Transmission</bold>
</p>
        <p>Intrapartum transmission is predicted to be the greatest risk of vertical infections. The risk increases with longer exposure to maternal cervicovaginal secretions and blood. Research also demonstrates that the chance of infection is greater with membrane rupture of more than&#x000a0;4 hours.<xref ref-type="bibr" rid="article-22930.r29">[29]</xref> Moreover, data also demonstrates that neonates with low birth weights and those born prematurely have an increased rate of transmission due to their reduced immunologic defenses and weaker skin barrier.<xref ref-type="bibr" rid="article-22930.r30">[30]</xref></p>
        <p>
<bold>Postnatal MTCT&#x000a0;</bold>
</p>
        <p>Postnatal MTCT occurs during breastfeeding. The mechanism of transmission through breast milk is not fully understood. However, multiple large prospective cohort trials have demonstrated a greater risk of spread of the HIV virus with breast-feeding. In addition to breast milk, studies have also confirmed that HIV RNA can also be found in colostrum.<xref ref-type="bibr" rid="article-22930.r31">[31]</xref><xref ref-type="bibr" rid="article-22930.r32">[32]</xref> Potential entry of the HIV virus from breast milk to the infant is through their intestines or tonsillar tissues.<xref ref-type="bibr" rid="article-22930.r33">[33]</xref><xref ref-type="bibr" rid="article-22930.r34">[34]</xref><xref ref-type="bibr" rid="article-22930.r35">[35]</xref><xref ref-type="bibr" rid="article-22930.r36">[36]</xref></p>
      </sec>
      <sec id="article-22930.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Due to the nature of the disease state, early identification of HIV may be difficult due to subtle clinical symptoms. As such, the use of histopathology of tissue samples may help identify HIV in patients. The capsid size of the HIV-1 virus varies between 110 and 146 nm.<xref ref-type="bibr" rid="article-22930.r37">[37]</xref> It can be visualized with structured illumination microscopy (SIM). It is almost impossible to visualize individual virions using confocal microscopy. Assessing the histopathology of the placenta may identify the presence of intrauterine HIV infection. Multiple studies have demonstrated that full-term placenta from HIV-1&#x02013;positive females contained infection in syncytiotrophoblasts, cytotrophoblasts, and villous-endothelial cells.<xref ref-type="bibr" rid="article-22930.r38">[38]</xref> In vitro, studies of trophoblast barriers have demonstrated that the direct interaction between the trophoblast barrier and HIV-1 infected cells resulted in viral transcytosis.<xref ref-type="bibr" rid="article-22930.r24">[24]</xref></p>
      </sec>
      <sec id="article-22930.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Neonates may not display any symptoms for the initial few months of life, as such complicating the diagnosis of HIV. Studies have suggested that children may remain asymptomatic until 3-5 years of age. In untreated children, the most commonly exhibited manifestations of HIV infection include but are not limited to recurrent bacteremia, increased opportunistic infections, frequent diarrhea, cardiomyopathy, hepatitis, generalized lymphadenopathy, splenomegaly, hepatomegaly, oral candidiasis, cancers, and central nervous system manifestations, such as growth delay, delayed cognition, low IQ, and frequently global developmental delay.</p>
        <p>The CDC strongly recommends testing all pregnant females for HIV as part of the standard prenatal care. This testing proves to have a better prognosis for the neonate. However, due to a lack of adequate healthcare access in certain geographical areas of the world, the unknown HIV status of pregnant females leads to inadequate treatment and poor outcomes for the neonate.<xref ref-type="bibr" rid="article-22930.r39">[39]</xref><xref ref-type="bibr" rid="article-22930.r40">[40]</xref> Females who have an unknown HIV status should be offered a rapid diagnostic test at the time of delivery. A definitive HIV diagnosis can be made in infants by the age of 4 to 6 months using virologic testing.</p>
      </sec>
      <sec id="article-22930.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Neonatal HIV diagnostics differs from that of adults and older children. It is not appropriate to test for HIV antibodies. The utilization of novel combination antigen/antibody immunoassays to confirm the diagnosis of HIV in neonates is not recommended as positive results confer passive transfer of maternal antibodies. Maternal HIV antibodies persist until 18 months.<xref ref-type="bibr" rid="article-22930.r5">[5]</xref><xref ref-type="bibr" rid="article-22930.r40">[40]</xref> Using viral load assays or nucleic acid tests (NATS), which include qualitative RNA assays, quantitative HIV RNA assay, or DNA polymerase chain reaction (PCR) assays, is more appropriate to confirm the diagnosis of HIV in neonates. The only FDA-approved qualitative RNA test is the APTIMA HIV-1 RNA Qualitative Assay.<xref ref-type="bibr" rid="article-22930.r41">[41]</xref> These assays are able to detect the virus in at least 30% to 50% of cases at birth and an almost 100% confirmation by the age of&#x000a0;4 to&#x000a0;6 months. HIV quantitative RNA assay has been found to be just as comparable to HIV DNA PCR, with 100% specificity at birth, 1 month, 3 months, and 6 months.<xref ref-type="bibr" rid="article-22930.r42">[42]</xref> Two negative virologic tests completed at&#x000a0;1 month and before 6 months of age are required to definitely exclude the diagnosis of HIV. Additionally, the infant must have negative clinical evidence and other laboratory markers of HIV, including normal to high CD4 T-lymphocyte count.<xref ref-type="bibr" rid="article-22930.r5">[5]</xref><xref ref-type="bibr" rid="article-22930.r43">[43]</xref></p>
        <p>Infants are categorized as high or low risk for HIV infection. Neonates born to mothers who received adequate prenatal care and were adherent to their ART, and who had undetectable viral loads are considered low risk. On the contrary, neonates are considered high risk if they were born to mothers who lacked prenatal care, had elevated HIV viral loads, and had a new diagnosis of HIV infection while pregnant.<xref ref-type="bibr" rid="article-22930.r5">[5]</xref></p>
        <p>The table below indicates (X) the proposed recommended testing schedule for HIV perinatal exposure.<xref ref-type="bibr" rid="article-22930.r43">[43]</xref><xref ref-type="bibr" rid="article-22930.r40">[40]</xref></p>
        <table-wrap id="article-22930.table0" position="float" orientation="portrait">
          <table>
            <tbody>
              <tr style="height: 35px;">
                <td style="height: 35px;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Birth&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>14-21 Days&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>1-2 Months</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>2-3 Months</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>4-6 Months</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Low risk of perinatal HIV transmission</p>
</td>
                <td style="height: 35px; text-align: center; vertical-align: middle;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="height: 35px; text-align: center; vertical-align: middle;" rowspan="1" colspan="1">
<p>X</p>
</td>
                <td style="height: 35px; text-align: center; vertical-align: middle;" rowspan="1" colspan="1">
<p>X</p>
</td>
                <td style="height: 35px; text-align: center; vertical-align: middle;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="height: 35px; text-align: center; vertical-align: middle;" rowspan="1" colspan="1">
<p>X</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>High risk of perinatal HIV transmission</p>
</td>
                <td style="height: 35px; text-align: center; vertical-align: middle;" rowspan="1" colspan="1">
<p>X</p>
</td>
                <td style="height: 35px; text-align: center; vertical-align: middle;" rowspan="1" colspan="1">
<p>X</p>
</td>
                <td style="height: 35px; text-align: center; vertical-align: middle;" rowspan="1" colspan="1">
<p>X</p>
</td>
                <td style="height: 35px; text-align: center; vertical-align: middle;" rowspan="1" colspan="1">
<p>X</p>
</td>
                <td style="height: 35px; text-align: center; vertical-align: middle;" rowspan="1" colspan="1">
<p>X</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>After a confirmed diagnosis of HIV, additional labs should be ordered, including CD4+ T-cell count, CD8+ T-cell count, plasma viral load of RNA, growth&#x000a0;or development factors, and HIV-associated conditions, such as anemia, leukopenia, thrombocytopenia, hepatic transaminitis, etc. Before initiating ART, obtain genetic testing, a baseline CD4 count, plasma viral load, complete blood count (CBC), hepatic function, renal function, comprehensive metabolic panel, urinalysis, serum lipids, and blood glucose.</p>
      </sec>
      <sec id="article-22930.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV strongly recommends the initiation of ART in all pediatrics with HIV.<xref ref-type="bibr" rid="article-22930.r44">[44]</xref> There has been a significant 80% to 90% decrease in morbidity and mortality since the introduction of ART initiation in neonates.<xref ref-type="bibr" rid="article-22930.r45">[45]</xref><xref ref-type="bibr" rid="article-22930.r46">[46]</xref>&#x000a0;As confirmed by the CHER trial and other studies, there is a decrease in viral reservoirs, opportunistic infections, and disease progression to AIDS with early initiation of effective and early ART.<xref ref-type="bibr" rid="article-22930.r47">[47]</xref><xref ref-type="bibr" rid="article-22930.r48">[48]</xref><xref ref-type="bibr" rid="article-22930.r49">[49]</xref><xref ref-type="bibr" rid="article-22930.r50">[50]</xref><xref ref-type="bibr" rid="article-22930.r51">[51]</xref><xref ref-type="bibr" rid="article-22930.r52">[52]</xref> Infants with any level of risk of exposure to HIV should be started on the appropriate ART within 6 hours of birth. The goals of treatment for HIV-exposed neonates include a reduction in morbidity and mortality, suppression of viral replication, facilitation of HIV remission, viral control, prevention of disease progression, maintenance of immunologic function, reduction of opportunistic infections, and prevention of drug resistance.<xref ref-type="bibr" rid="article-22930.r53">[53]</xref><xref ref-type="bibr" rid="article-22930.r54">[54]</xref>&#x000a0;</p>
        <p>There aren&#x02019;t many randomized control trials that compare different regimens in pediatrics and neonates, and the available literature is variable. Most of the data is extracted from non-randomized studies, pharmacokinetic trials, and phase 1 or 2 of drug trials. In general, the initiation of an antiretroviral regimen in pediatrics should include&#x000a0;2 nucleoside reverse transcriptase inhibitors (NRTIs) with an additional drug from another class, including an integrase strand transfer inhibitor (INSTI), a protease inhibitor (PI) with a booster, or a non-nucleoside reverse transcriptase inhibitor (NNRTI). Before initiating a regimen, Factors to consider include the patient&#x02019;s age, weight, family preference, drug resistance, genetic testing, mutation testing, and sexual maturity rating (SMR). In children with other confections, such as hepatitis B virus (HBV), the choice of agent should include coverage for HIV and the co-contagion.&#x000a0;</p>
        <p>There are&#x000a0;3 studies that compared the addition of a PI-boosted versus NNRTI to the 2 NRTI backbones. In the P1060 trial, a total of 288 children from&#x000a0;6 African countries and India with ages from 2&#x000a0;to 36 months were enrolled in a randomized trial. The children received zidovudine (ZDV) plus lamivudine as the NRTI backbone and were randomized to either the PI with booster group (ritonavir booster [LPV/r]) or NNRTI group (nevirapine [NVP]). The data demonstrated that LPV/r is superior to NVP in NVP-naive children; however, there were limitations.<xref ref-type="bibr" rid="article-22930.r55">[55]</xref>&#x000a0;Whereas the PROMOTE trial did not find any differences between the&#x000a0;2 groups.<xref ref-type="bibr" rid="article-22930.r56">[56]</xref> Of note, LPV/r should be avoided in neonates before 42 weeks of age and those who are younger than 14 days.</p>
        <p>Data for utilizing an INSTI-based regimen&#x000a0;are extracted from safety trials and adult comparative trials. Four INSTIs are approved for the treatment of ART-na&#x000ef;ve children with HIV, which include: bictegravir (BID), dolutegrevir (DTG), Elvitegravir/cobicistat (EVG/c), and raltegravir (RAL).<xref ref-type="bibr" rid="article-22930.r57">[57]</xref> INSTI regimens are attractive due to their lack of drug interactions, low toxicity, and virologic efficacy. RAL is FDA-approved for neonates and infants weighing 2 kg or more. DTG is FDA-approved for children 30 kg or more, and BIC is approved for children weighing 25 kg or more.<xref ref-type="bibr" rid="article-22930.r58">[58]</xref><xref ref-type="bibr" rid="article-22930.r59">[59]</xref></p>
        <p>Zidovudine (ZDV) plus lamivudine (3TC) or emtricitabine (FTC) are the preferred dual NRTI backbone in neonates and infants&#x000a0;under 3 months. ZDV is FDA-approved for prophylaxis and for HIV treatment initiation in infants &#x02265; 4 weeks of age.<xref ref-type="bibr" rid="article-22930.r60">[60]</xref><xref ref-type="bibr" rid="article-22930.r61">[61]</xref><xref ref-type="bibr" rid="article-22930.r62">[62]</xref><xref ref-type="bibr" rid="article-22930.r63">[63]</xref>&#x000a0;The preferred regimen for infants 3 months and older is abacavir (ABC) plus 3TC or FTC.<xref ref-type="bibr" rid="article-22930.r64">[64]</xref><xref ref-type="bibr" rid="article-22930.r65">[65]</xref><xref ref-type="bibr" rid="article-22930.r66">[66]</xref><xref ref-type="bibr" rid="article-22930.r67">[67]</xref> Alternatively, ZDV plus ABC can be used in infants 3 months and older; however, European studies have demonstrated lower rates of viral suppression and increased toxicity with this combination.<xref ref-type="bibr" rid="article-22930.r65">[65]</xref><xref ref-type="bibr" rid="article-22930.r68">[68]</xref>&#x000a0;In addition to the&#x000a0;2 NRTI backbones, the following combination regimens are preferred in each age group:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>NVP: </bold>Age&#x000a0;under 14 days&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>RAL: </bold>Age&#x000a0;under 14 days and a weight of 2 kg or more</p>
          </list-item>
          <list-item>
            <p><bold>LPV/r or RAL (alternative: NVP): </bold>Age 14 days or older to 3 years&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22930.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>There are other diseases that need exclusion when diagnosing HIV. These include malnutrition, lymphadenopathy, pediatric chronic anemia, malabsorption syndrome, constitutional growth delay, autoimmune and chronic benign neutropenia, and other immunodeficiencies. Furthermore, the clinician should also look for other congenital co-infections, including syphilis, TORCH infections (Toxoplasmosis, Rubella, Cytomegalovirus, herpes simplex virus), hepatitis B, hepatitis C, or tuberculosis infection.</p>
      </sec>
      <sec id="article-22930.s11" sec-type="Toxicity and Adverse Effect Management">
        <title>Toxicity and Adverse Effect Management</title>
        <p>Any ART is associated with a variety of side effects. Many ARTs result in increased levels of hepatic transaminases as a result of hepatitis. Baseline labs are recommended before initiation of any regimen.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Zidovudine:</bold>&#x000a0;Can induce leukopenia, anemia, and macrocytosis</p>
          </list-item>
          <list-item>
            <p><bold>Protease inhibitors:</bold> May lead to hyperglycemia</p>
          </list-item>
          <list-item>
            <p><bold>Atazanavir:</bold> Can cause hyperbilirubinemia.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22930.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>If untreated, HIV can increase the rate of morbidity and mortality. However, due to the advancement of ART, increased monitoring, and data from clinical trials, pediatric and adult patients have better prognoses and outcomes. The average survival rate is about 10 years of age, with approximately 15% of children having a rapid progression of the disease. The clinician should collaborate with the patient to optimize their nutrition, control viral replication, initiate aggressive treatment for opportunistic infections, and decrease social stressors. The risk of complications is greater with co-infections and hematological disturbances, such as anemia, thrombocytopenia, and neutropenia.</p>
      </sec>
      <sec id="article-22930.s13" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of HIV infection in neonates and pediatric populations occur as a result of their immunocompromised status. They are at greater risk for opportunistic infections, candida esophagitis, <italic toggle="yes">Pneumocystis jirovecii</italic> pneumonia, and cancers. Furthermore, complications are more likely to occur with antiretroviral drug resistance. However, with careful monitoring and drug-resistance testing, the ability to select more optimized and effective regimens is possible.</p>
      </sec>
      <sec id="article-22930.s14" sec-type="Consultations">
        <title>Consultations</title>
        <p>Consultation with a perinatologist and a pediatric infectious disease consultant is strongly encouraged to help provide a more comprehensive workup, diagnosis, and ongoing monitoring and management.</p>
      </sec>
      <sec id="article-22930.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Before initiating or altering ART, the clinician should identify potential barriers and compliance issues. Developing novel drugs and enhanced formulations has led to better medication tolerability, less toxicity, and increased adherence.</p>
        <p>HIV-positive mothers should be discouraged from breastfeeding neonates who do not have a confirmed HIV-positive status. If a female continues to breastfeed, the infant should be monitored and tested every 3 months throughout breastfeeding and postdiscontinuation of breastfeeding at the interval of 4&#x000a0;to 6 weeks, 3 months, and at 6 months.<xref ref-type="bibr" rid="article-22930.r69">[69]</xref><xref ref-type="bibr" rid="article-22930.r70">[70]</xref> Mothers should also be warned about the risks of feeding premasticated food to the infant.<xref ref-type="bibr" rid="article-22930.r71">[71]</xref><xref ref-type="bibr" rid="article-22930.r72">[72]</xref><xref ref-type="bibr" rid="article-22930.r73">[73]</xref></p>
      </sec>
      <sec id="article-22930.s16" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Key facts to keep in mind about&#x000a0;neonatal HIV are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>When making a selection for appropriate ART to initiate in a pregnant female, it is important to consider tolerability, neonatal risk of exposure, pharmacokinetic differences, and overall risk-benefit of each regimen.</p>
          </list-item>
          <list-item>
            <p>The monitoring of infants with HIV is challenging as there is variability with viral loads and CD4 counts depending on the age.</p>
          </list-item>
          <list-item>
            <p>Studies have demonstrated that administering zidovudine (ZDV) monotherapy to both the mother and neonate reduces MTCT from 25% to 8%. The MTCT rate is reduced to less than 1% when combined with other ART.<xref ref-type="bibr" rid="article-22930.r7">[7]</xref> ZDV exhibits its actions by metabolizing into its active form in the placenta, thus inhibiting the replication of HIV within the placental cells.</p>
          </list-item>
          <list-item>
            <p>Repeated negative HIV test results are needed postpartum due to the increased risk of transmission of HIV during labor and delivery.<xref ref-type="bibr" rid="article-22930.r5">[5]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22930.s17" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The treatment of perinatal HIV exposure involves a team approach involving an infectious disease specialist, perinatalist, pediatrician, neonatologist, obstetrician, HIV pharmacist, and nursing staff. Prompt and early communication between all team members assures comprehensive and optimized care for the neonate. Infectious disease specialists and neonatologists are usually involved in acute management during the neonatal period. Infectious disease specialists are responsible for monitoring disease progression and drug regimens.</p>
      </sec>
      <sec id="article-22930.s18">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22930&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22930">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/neonatal-hiv/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=22930">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22930/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22930">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-22930.s19">
        <title>References</title>
        <ref id="article-22930.r1">
          <label>1</label>
          <element-citation publication-type="book">
            <source>Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach</source>
            <publisher-name>World Health Organization</publisher-name>
            <publisher-loc>Geneva</publisher-loc>
            <year>2013</year>
            <month>06</month>
            <pub-id pub-id-type="pmid">24716260</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hurst</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Appelgren</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Kourtis</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Prevention of mother-to-child transmission of HIV type 1: the role of neonatal and infant prophylaxis.</article-title>
            <source>Expert Rev Anti Infect Ther</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>169</fpage>
            <page-range>169-81</page-range>
            <pub-id pub-id-type="pmid">25578882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Worobey</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gemmel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Teuwen</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Haselkorn</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kunstman</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bunce</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Muyembe</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Kabongo</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kalengayi</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Van Marck</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gilbert</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Wolinsky</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960.</article-title>
            <source>Nature</source>
            <year>2008</year>
            <month>Oct</month>
            <day>02</day>
            <volume>455</volume>
            <issue>7213</issue>
            <fpage>661</fpage>
            <page-range>661-4</page-range>
            <pub-id pub-id-type="pmid">18833279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mofenson</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Mother-child HIV-1 transmission: Timing and determinants.</article-title>
            <source>Obstet Gynecol Clin North Am</source>
            <year>1997</year>
            <month>Dec</month>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>759</fpage>
            <page-range>759-84</page-range>
            <pub-id pub-id-type="pmid">9430166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siberry</surname>
                <given-names>GK</given-names>
              </name>
            </person-group>
            <article-title>Preventing and managing HIV infection in infants, children, and adolescents in the United States.</article-title>
            <source>Pediatr Rev</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>35</volume>
            <issue>7</issue>
            <fpage>268</fpage>
            <page-range>268-86</page-range>
            <pub-id pub-id-type="pmid">24986927</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bispo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chikhungu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rollins</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Siegfried</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Newell</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Postnatal HIV transmission in breastfed infants of HIV-infected women on ART: a systematic review and meta-analysis.</article-title>
            <source>J Int AIDS Soc</source>
            <year>2017</year>
            <month>Feb</month>
            <day>22</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>21251</fpage>
            <pub-id pub-id-type="pmid">28362072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bansaccal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Van der Linden</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Marot</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Belkhir</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>HIV-Infected Mothers Who Decide to Breastfeed Their Infants Under Close Supervision in Belgium: About Two Cases.</article-title>
            <source>Front Pediatr</source>
            <year>2020</year>
            <volume>8</volume>
            <fpage>248</fpage>
            <pub-id pub-id-type="pmid">32537442</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Connor</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Sperling</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Gelber</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kiselev</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>O'Sullivan</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>VanDyke</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bey</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shearer</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Jacobson</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.</article-title>
            <source>N Engl J Med</source>
            <year>1994</year>
            <month>Nov</month>
            <day>03</day>
            <volume>331</volume>
            <issue>18</issue>
            <fpage>1173</fpage>
            <page-range>1173-80</page-range>
            <pub-id pub-id-type="pmid">7935654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shaffer</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Chuachoowong</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mock</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Bhadrakom</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Siriwasin</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Chotpitayasunondh</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chearskul</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Roongpisuthipong</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chinayon</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Karon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mastro</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Simonds</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group.</article-title>
            <source>Lancet</source>
            <year>1999</year>
            <month>Mar</month>
            <day>06</day>
            <volume>353</volume>
            <issue>9155</issue>
            <fpage>773</fpage>
            <page-range>773-80</page-range>
            <pub-id pub-id-type="pmid">10459957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jamieson</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Sibailly</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Sadek</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Roels</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Ekpini</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Boni-Ouattara</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Karon</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Nkengasong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Wiktor</surname>
                <given-names>SZ</given-names>
              </name>
            </person-group>
            <article-title>HIV-1 viral load and other risk factors for mother-to-child transmission of HIV-1 in a breast-feeding population in Cote d'Ivoire.</article-title>
            <source>J Acquir Immune Defic Syndr</source>
            <year>2003</year>
            <month>Dec</month>
            <day>01</day>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>430</fpage>
            <page-range>430-6</page-range>
            <pub-id pub-id-type="pmid">14615662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jackson</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Musoke</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fleming</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Guay</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Bagenda</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nakabiito</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sherman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bakaki</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Owor</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ducar</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Deseyve</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mwatha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Emel</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Duefield</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mirochnick</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Mofenson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Miotti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gigliotti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bray</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mmiro</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.</article-title>
            <source>Lancet</source>
            <year>2003</year>
            <month>Sep</month>
            <day>13</day>
            <volume>362</volume>
            <issue>9387</issue>
            <fpage>859</fpage>
            <page-range>859-68</page-range>
            <pub-id pub-id-type="pmid">13678973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>John</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Nduati</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Mbori-Ngacha</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Richardson</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Panteleeff</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mwatha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Overbaugh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bwayo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ndinya-Achola</surname>
                <given-names>JO</given-names>
              </name>
              <name>
                <surname>Kreiss</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections.</article-title>
            <source>J Infect Dis</source>
            <year>2001</year>
            <month>Jan</month>
            <day>15</day>
            <volume>183</volume>
            <issue>2</issue>
            <fpage>206</fpage>
            <page-range>206-212</page-range>
            <pub-id pub-id-type="pmid">11120927</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kempton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Levi</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Heath</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pozniak</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Most new HIV infections, vertical transmissions and AIDS-related deaths occur in lower-prevalence countries.</article-title>
            <source>J Virus Erad</source>
            <year>2019</year>
            <month>Apr</month>
            <day>01</day>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>92</fpage>
            <page-range>92-101</page-range>
            <pub-id pub-id-type="pmid">31191912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nesheim</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Wiener</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fitz Harris</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Lampe</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Weidle</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Brief Report: Estimated Incidence of Perinatally Acquired HIV Infection in the United States, 1978-2013.</article-title>
            <source>J Acquir Immune Defic Syndr</source>
            <year>2017</year>
            <month>Dec</month>
            <day>15</day>
            <volume>76</volume>
            <issue>5</issue>
            <fpage>461</fpage>
            <page-range>461-464</page-range>
            <pub-id pub-id-type="pmid">28991886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peters</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Francis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sconza</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Horn</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>S Peckham</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tookey</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Thorne</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>UK Mother-to-Child HIV Transmission Rates Continue to Decline: 2012-2014.</article-title>
            <source>Clin Infect Dis</source>
            <year>2017</year>
            <month>Feb</month>
            <day>15</day>
            <volume>64</volume>
            <issue>4</issue>
            <fpage>527</fpage>
            <page-range>527-528</page-range>
            <pub-id pub-id-type="pmid">28174911</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nesheim</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>FitzHarris</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Lampe</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Reconsidering the Number of Women With HIV Infection Who Give Birth Annually in the United States.</article-title>
            <source>Public Health Rep</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>133</volume>
            <issue>6</issue>
            <fpage>637</fpage>
            <page-range>637-643</page-range>
            <pub-id pub-id-type="pmid">30265616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peters</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Thorne</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tookey</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Byrne</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>National audit of perinatal HIV infections in the UK, 2006-2013: what lessons can be learnt?</article-title>
            <source>HIV Med</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>280</fpage>
            <page-range>280-289</page-range>
            <pub-id pub-id-type="pmid">29336508</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nesheim</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>FitzHarris</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Mahle Gray</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lampe</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of Perinatal HIV Transmission in the United States in the Era of Its Elimination.</article-title>
            <source>Pediatr Infect Dis J</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>38</volume>
            <issue>6</issue>
            <fpage>611</fpage>
            <page-range>611-616</page-range>
            <pub-id pub-id-type="pmid">30724833</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maartens</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Celum</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lewin</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>HIV infection: epidemiology, pathogenesis, treatment, and prevention.</article-title>
            <source>Lancet</source>
            <year>2014</year>
            <month>Jul</month>
            <day>19</day>
            <volume>384</volume>
            <issue>9939</issue>
            <fpage>258</fpage>
            <page-range>258-71</page-range>
            <pub-id pub-id-type="pmid">24907868</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lucas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>HIV and the spectrum of human disease.</article-title>
            <source>J Pathol</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>235</volume>
            <issue>2</issue>
            <fpage>229</fpage>
            <page-range>229-41</page-range>
            <pub-id pub-id-type="pmid">25251832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahmad</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Molecular mechanisms of HIV-1 mother-to-child transmission and infection in neonatal target cells.</article-title>
            <source>Life Sci</source>
            <year>2011</year>
            <month>May</month>
            <day>23</day>
            <volume>88</volume>
            <issue>21-22</issue>
            <fpage>980</fpage>
            <page-range>980-6</page-range>
            <pub-id pub-id-type="pmid">20888841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Little</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Thorne</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bunders</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ngongo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>McDermott</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Newell</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Disease progression in children with vertically-acquired HIV infection in sub-Saharan Africa: reviewing the need for HIV treatment.</article-title>
            <source>Curr HIV Res</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>139</fpage>
            <page-range>139-53</page-range>
            <pub-id pub-id-type="pmid">17346131</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saharan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lodha</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Deorari</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>VK</given-names>
              </name>
            </person-group>
            <article-title>Perinatal HIV.</article-title>
            <source>Indian J Pediatr</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>75</volume>
            <issue>4</issue>
            <fpage>359</fpage>
            <page-range>359-62</page-range>
            <pub-id pub-id-type="pmid">18536891</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Husaini</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Role of placenta in the vertical transmission of human immunodeficiency virus.</article-title>
            <source>J Perinatol</source>
            <year>2009</year>
            <month>May</month>
            <volume>29</volume>
            <issue>5</issue>
            <fpage>331</fpage>
            <page-range>331-6</page-range>
            <pub-id pub-id-type="pmid">19020526</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ehrnst</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lindgren</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dictor</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Johansson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>S&#x000f6;nnerborg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Czajkowski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sundin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bohlin</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>HIV in pregnant women and their offspring: evidence for late transmission.</article-title>
            <source>Lancet</source>
            <year>1991</year>
            <month>Jul</month>
            <day>27</day>
            <volume>338</volume>
            <issue>8761</issue>
            <fpage>203</fpage>
            <page-range>203-7</page-range>
            <pub-id pub-id-type="pmid">1676777</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rouzioux</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Costagliola</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Burgard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blanche</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mayaux</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Griscelli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Valleron</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. The HIV Infection in Newborns French Collaborative Study Group.</article-title>
            <source>Am J Epidemiol</source>
            <year>1995</year>
            <month>Dec</month>
            <day>15</day>
            <volume>142</volume>
            <issue>12</issue>
            <fpage>1330</fpage>
            <page-range>1330-7</page-range>
            <pub-id pub-id-type="pmid">7503054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bornstein</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Qualities of color vision in infancy.</article-title>
            <source>J Exp Child Psychol</source>
            <year>1975</year>
            <month>Jun</month>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>401</fpage>
            <page-range>401-19</page-range>
            <pub-id pub-id-type="pmid">1176886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>King</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Ellington</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Kourtis</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>The role of co-infections in mother-to-child transmission of HIV.</article-title>
            <source>Curr HIV Res</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <page-range>10-23</page-range>
            <pub-id pub-id-type="pmid">23305198</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Landesman</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kalish</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Burns</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Minkoff</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Zorrilla</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Mofenson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tuomala</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study.</article-title>
            <source>N Engl J Med</source>
            <year>1996</year>
            <month>Jun</month>
            <day>20</day>
            <volume>334</volume>
            <issue>25</issue>
            <fpage>1617</fpage>
            <page-range>1617-23</page-range>
            <pub-id pub-id-type="pmid">8628356</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kourtis</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Bulterys</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nesheim</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>FK</given-names>
              </name>
            </person-group>
            <article-title>Understanding the timing of HIV transmission from mother to infant.</article-title>
            <source>JAMA</source>
            <year>2001</year>
            <month>Feb</month>
            <day>14</day>
            <volume>285</volume>
            <issue>6</issue>
            <fpage>709</fpage>
            <page-range>709-12</page-range>
            <pub-id pub-id-type="pmid">11176886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van de Perre</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Simonon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Msellati</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hitimana</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Vaira</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bazubagira</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Van Goethem</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stevens</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Karita</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sondag-Thull</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda.</article-title>
            <source>N Engl J Med</source>
            <year>1991</year>
            <month>Aug</month>
            <day>29</day>
            <volume>325</volume>
            <issue>9</issue>
            <fpage>593</fpage>
            <page-range>593-8</page-range>
            <pub-id pub-id-type="pmid">1812850</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van de Perre</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lepage</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Homsy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dabis</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Mother-to-infant transmission of human immunodeficiency virus by breast milk: presumed innocent or presumed guilty?</article-title>
            <source>Clin Infect Dis</source>
            <year>1992</year>
            <month>Sep</month>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>502</fpage>
            <page-range>502-7</page-range>
            <pub-id pub-id-type="pmid">1445596</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lehman</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Farquhar</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Biological mechanisms of vertical human immunodeficiency virus (HIV-1) transmission.</article-title>
            <source>Rev Med Virol</source>
            <year>2007</year>
            <season>Nov-Dec</season>
            <volume>17</volume>
            <issue>6</issue>
            <fpage>381</fpage>
            <page-range>381-403</page-range>
            <pub-id pub-id-type="pmid">17542053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Smythies</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Clements</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Novak</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>Dendritic cells transmit HIV-1 through human small intestinal mucosa.</article-title>
            <source>J Leukoc Biol</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>87</volume>
            <issue>4</issue>
            <fpage>663</fpage>
            <page-range>663-70</page-range>
            <pub-id pub-id-type="pmid">20007245</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Veazey</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lackner</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The mucosal immune system and HIV-1 infection.</article-title>
            <source>AIDS Rev</source>
            <year>2003</year>
            <season>Oct-Dec</season>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>245</fpage>
            <page-range>245-52</page-range>
            <pub-id pub-id-type="pmid">15012003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lapenta</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Boirivant</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Santini</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Logozzi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Viora</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Belardelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fais</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Human intestinal lamina propria lymphocytes are naturally permissive to HIV-1 infection.</article-title>
            <source>Eur J Immunol</source>
            <year>1999</year>
            <month>Apr</month>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>1202</fpage>
            <page-range>1202-8</page-range>
            <pub-id pub-id-type="pmid">10229087</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marno</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Al'Zoubi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pearson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Posch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McKnight</surname>
                <given-names>&#x000c1;</given-names>
              </name>
              <name>
                <surname>Wheeler</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>The evolution of structured illumination microscopy in studies of HIV.</article-title>
            <source>Methods</source>
            <year>2015</year>
            <month>Oct</month>
            <day>15</day>
            <volume>88</volume>
            <fpage>20</fpage>
            <page-range>20-7</page-range>
            <pub-id pub-id-type="pmid">26071977</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moonim</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Alarcon</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Freeman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mahadeva</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>van der Walt</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Lucas</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>Identifying HIV infection in diagnostic histopathology tissue samples--the role of HIV-1 p24 immunohistochemistry in identifying clinically unsuspected HIV infection: a 3-year analysis.</article-title>
            <source>Histopathology</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>56</volume>
            <issue>4</issue>
            <fpage>530</fpage>
            <page-range>530-41</page-range>
            <pub-id pub-id-type="pmid">20459560</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gilleece</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Tariq</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Bamford</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Bhagani</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Byrne</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Clarke</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Clayden</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Lyall</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Metcalfe</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Palfreeman</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Rubinstein</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Sonecha</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Thorley</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Tookey</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Tosswill</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Utting</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Welch</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>British HIV Association guidelines for the management of HIV in pregnancy and postpartum 2018.</article-title>
            <source>HIV Med</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>20 Suppl 3</volume>
            <fpage>s2</fpage>
            <page-range>s2-s85</page-range>
            <pub-id pub-id-type="pmid">30869192</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abdollahi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saffar</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>The Diagnosis of HIV Infection in Infants and Children.</article-title>
            <source>Iran J Pathol</source>
            <year>2016</year>
            <season>Spring</season>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>89</fpage>
            <page-range>89-96</page-range>
            <pub-id pub-id-type="pmid">27499768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lilian</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Kalk</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bhowan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Berrie</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Carmona</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Technau</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sherman</surname>
                <given-names>GG</given-names>
              </name>
            </person-group>
            <article-title>Early diagnosis of in utero and intrapartum HIV infection in infants prior to 6 weeks of age.</article-title>
            <source>J Clin Microbiol</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>50</volume>
            <issue>7</issue>
            <fpage>2373</fpage>
            <page-range>2373-7</page-range>
            <pub-id pub-id-type="pmid">22518871</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burgard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blanche</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jasseron</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Descamps</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Allemon</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Ciraru-Vigneron</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Floch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Heller-Roussin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lachassinne</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mazy</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Warszawski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rouzioux</surname>
                <given-names>C</given-names>
              </name>
              <collab>Agence Nationale de Recherche sur le SIDA et les Hepatites virales French Perinatal Cohort</collab>
            </person-group>
            <article-title>Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during anti-retroviral prophylaxis.</article-title>
            <source>J Pediatr</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>160</volume>
            <issue>1</issue>
            <fpage>60</fpage>
            <page-range>60-6.e1</page-range>
            <pub-id pub-id-type="pmid">21868029</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Havens</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Mofenson</surname>
                <given-names>LM</given-names>
              </name>
              <collab>American Academy of Pediatrics Committee on Pediatric AIDS</collab>
            </person-group>
            <article-title>Evaluation and management of the infant exposed to HIV-1 in the United States.</article-title>
            <source>Pediatrics</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>123</volume>
            <issue>1</issue>
            <fpage>175</fpage>
            <page-range>175-87</page-range>
            <pub-id pub-id-type="pmid">19117880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Foster</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bamford</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Turkova</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Welch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>N</given-names>
              </name>
              <collab>PENTA Guidelines Writing Group and PENTA steering committee</collab>
            </person-group>
            <article-title>Paediatric European Network for Treatment of AIDS Treatment Guideline 2016 update: antiretroviral therapy recommended for all children living with HIV.</article-title>
            <source>HIV Med</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>133</fpage>
            <page-range>133-134</page-range>
            <pub-id pub-id-type="pmid">27385585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kapogiannis</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Soe</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Nesheim</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Abrams</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Farley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Palumbo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Koenig</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Bulterys</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).</article-title>
            <source>Clin Infect Dis</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>53</volume>
            <issue>10</issue>
            <fpage>1024</fpage>
            <page-range>1024-34</page-range>
            <pub-id pub-id-type="pmid">22002982</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mirani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Chernoff</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Abzug</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Seage</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Oleske</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Purswani</surname>
                <given-names>MU</given-names>
              </name>
              <name>
                <surname>Hazra</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Traite</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zimmer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Van Dyke</surname>
                <given-names>RB</given-names>
              </name>
              <collab>IMPAACT P1074 Study Team</collab>
            </person-group>
            <article-title>Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral Therapy.</article-title>
            <source>Clin Infect Dis</source>
            <year>2015</year>
            <month>Dec</month>
            <day>15</day>
            <volume>61</volume>
            <issue>12</issue>
            <fpage>1850</fpage>
            <page-range>1850-61</page-range>
            <pub-id pub-id-type="pmid">26270680</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Violari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cotton</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Gibb</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Babiker</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Steyn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Madhi</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Jean-Philippe</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>McIntyre</surname>
                <given-names>JA</given-names>
              </name>
              <collab>CHER Study Team</collab>
            </person-group>
            <article-title>Early antiretroviral therapy and mortality among HIV-infected infants.</article-title>
            <source>N Engl J Med</source>
            <year>2008</year>
            <month>Nov</month>
            <day>20</day>
            <volume>359</volume>
            <issue>21</issue>
            <fpage>2233</fpage>
            <page-range>2233-44</page-range>
            <pub-id pub-id-type="pmid">19020325</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuhn</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Paximadis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Da Costa Dias</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Loubser</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Strehlau</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Shiau</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Coovadia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abrams</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Tiemessen</surname>
                <given-names>CT</given-names>
              </name>
            </person-group>
            <article-title>Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children.</article-title>
            <source>PLoS One</source>
            <year>2018</year>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>e0195514</fpage>
            <pub-id pub-id-type="pmid">29649264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tagarro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zangari</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ferns</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>De Rossi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nastouli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;oz-Fern&#x000e1;ndez</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Gibb</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rossi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Giaquinto</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Babiker</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fortuny</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Freguja</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cotugno</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Judd</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Noguera-Julian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Navarro</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Mellado</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Palma</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rojo</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Early and Highly Suppressive Antiretroviral Therapy Are Main Factors Associated With Low Viral Reservoir in European Perinatally HIV-Infected Children.</article-title>
            <source>J Acquir Immune Defic Syndr</source>
            <year>2018</year>
            <month>Oct</month>
            <day>01</day>
            <volume>79</volume>
            <issue>2</issue>
            <fpage>269</fpage>
            <page-range>269-276</page-range>
            <pub-id pub-id-type="pmid">30211778</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nesheim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lampe</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Kilmarx</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Fitz Harris</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Whitmore</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Griffith</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thomas-Proctor</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fenton</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mermin</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>A framework for elimination of perinatal transmission of HIV in the United States.</article-title>
            <source>Pediatrics</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>130</volume>
            <issue>4</issue>
            <fpage>738</fpage>
            <page-range>738-44</page-range>
            <pub-id pub-id-type="pmid">22945404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <collab>Centers for Disease Control and Prevention (CDC)</collab>
            <article-title>Revised surveillance case definition for HIV infection--United States, 2014.</article-title>
            <source>MMWR Recomm Rep</source>
            <year>2014</year>
            <month>Apr</month>
            <day>11</day>
            <volume>63</volume>
            <issue>RR-03</issue>
            <fpage>1</fpage>
            <page-range>1-10</page-range>
            <pub-id pub-id-type="pmid">24717910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flynn</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Abrams</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Growing up with perinatal HIV.</article-title>
            <source>AIDS</source>
            <year>2019</year>
            <month>Mar</month>
            <day>15</day>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>597</fpage>
            <page-range>597-603</page-range>
            <pub-id pub-id-type="pmid">30531318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuhn</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shiau</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The pharmacological treatment of acute HIV infections in neonates.</article-title>
            <source>Expert Rev Clin Pharmacol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>12</issue>
            <fpage>1353</fpage>
            <page-range>1353-1361</page-range>
            <pub-id pub-id-type="pmid">29098898</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mofenson</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Brady</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Danner</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Dominguez</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Hazra</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Handelsman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Havens</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nesheim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Read</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Serchuck</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Van Dyke</surname>
                <given-names>R</given-names>
              </name>
              <collab>Centers for Disease Control and Prevention</collab>
              <collab>National Institutes of Health</collab>
              <collab>HIV Medicine Association of the Infectious Diseases Society of America</collab>
              <collab>Pediatric Infectious Diseases Society</collab>
              <collab>American Academy of Pediatrics</collab>
            </person-group>
            <article-title>Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.</article-title>
            <source>MMWR Recomm Rep</source>
            <year>2009</year>
            <month>Sep</month>
            <day>04</day>
            <volume>58</volume>
            <issue>RR-11</issue>
            <fpage>1</fpage>
            <page-range>1-166</page-range>
            <pub-id pub-id-type="pmid">19730409</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Violari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lindsey</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Mujuru</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Barlow-Mosha</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kamthunzi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chi</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Cotton</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Moultrie</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Khadse</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schimana</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bobat</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Purdue</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Eshleman</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Abrams</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Millar</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Petzold</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mofenson</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Jean-Philippe</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Palumbo</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.</article-title>
            <source>N Engl J Med</source>
            <year>2012</year>
            <month>Jun</month>
            <day>21</day>
            <volume>366</volume>
            <issue>25</issue>
            <fpage>2380</fpage>
            <page-range>2380-9</page-range>
            <pub-id pub-id-type="pmid">22716976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ruel</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Kakuru</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ikilezi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mwangwa</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dorsey</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rosenthal</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Charlebois</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Havlir</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kamya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Achan</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Virologic and immunologic outcomes of HIV-infected Ugandan children randomized to lopinavir/ritonavir or nonnucleoside reverse transcriptase inhibitor therapy.</article-title>
            <source>J Acquir Immune Defic Syndr</source>
            <year>2014</year>
            <month>Apr</month>
            <day>15</day>
            <volume>65</volume>
            <issue>5</issue>
            <fpage>535</fpage>
            <page-range>535-41</page-range>
            <pub-id pub-id-type="pmid">24326597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsiang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Goldsmith</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mulato</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bam</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Stepan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Stray</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Niedziela-Majka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yant</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kukolj</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cihlar</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lazerwith</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>60</volume>
            <issue>12</issue>
            <fpage>7086</fpage>
            <page-range>7086-7097</page-range>
            <pub-id pub-id-type="pmid">27645238</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oliveira</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ibanescu</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Anstett</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>M&#x000e9;spl&#x000e8;de</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Routy</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Robbins</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Brenner</surname>
                <given-names>BG</given-names>
              </name>
              <collab>Montreal Primary HIV (PHI) Cohort Study Group</collab>
            </person-group>
            <article-title>Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir.</article-title>
            <source>Retrovirology</source>
            <year>2018</year>
            <month>Aug</month>
            <day>17</day>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>56</fpage>
            <pub-id pub-id-type="pmid">30119633</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neogi</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Aralaguppe</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Njenda</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Sarafianos</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Hejdeman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>S&#x000f6;nnerborg</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes.</article-title>
            <source>AIDS</source>
            <year>2018</year>
            <month>Feb</month>
            <day>20</day>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>469</fpage>
            <page-range>469-476</page-range>
            <pub-id pub-id-type="pmid">29239896</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mulenga</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Musiime</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kekitiinwa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Abongomera</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kenny</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chabala</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mirembe</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Asiimwe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Owen-Powell</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Burger</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>McIlleron</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Chintu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Thomason</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Kityo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Gibb</surname>
                <given-names>DM</given-names>
              </name>
              <collab>CHAPAS-3 trial team</collab>
            </person-group>
            <article-title>Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>169</fpage>
            <page-range>169-79</page-range>
            <pub-id pub-id-type="pmid">26481928</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Dyke</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>PL</given-names>
              </name>
              <collab>Pediatric AIDS Clinical Trials Group 219C Team</collab>
            </person-group>
            <article-title>Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children.</article-title>
            <source>J Infect Dis</source>
            <year>2008</year>
            <month>Dec</month>
            <day>01</day>
            <volume>198</volume>
            <issue>11</issue>
            <fpage>1599</fpage>
            <page-range>1599-608</page-range>
            <pub-id pub-id-type="pmid">19000014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moyle</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Sabin</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Cartledge</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wilkins</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Churchill</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hay</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fakoya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Scullard</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Leen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Reilly</surname>
                <given-names>G</given-names>
              </name>
              <collab>RAVE (Randomized Abacavir versus Viread Evaluation) Group UK</collab>
            </person-group>
            <article-title>A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy.</article-title>
            <source>AIDS</source>
            <year>2006</year>
            <month>Oct</month>
            <day>24</day>
            <volume>20</volume>
            <issue>16</issue>
            <fpage>2043</fpage>
            <page-range>2043-50</page-range>
            <pub-id pub-id-type="pmid">17053350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carr</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Workman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Hoy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hudson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Doong</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Amin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Freund</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Law</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>DA</given-names>
              </name>
              <collab>Mitochondrial Toxicity (MITOX) Study Group</collab>
            </person-group>
            <article-title>Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.</article-title>
            <source>JAMA</source>
            <year>2002</year>
            <month>Jul</month>
            <day>10</day>
            <volume>288</volume>
            <issue>2</issue>
            <fpage>207</fpage>
            <page-range>207-15</page-range>
            <pub-id pub-id-type="pmid">12095385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DeJesus</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rockstroh</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Lennox</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Saag</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Lazzarin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Rodgers</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>DiNubile</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>BY</given-names>
              </name>
              <name>
                <surname>Teppler</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Leavitt</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sklar</surname>
                <given-names>P</given-names>
              </name>
              <collab>STARTMRK Investigators</collab>
            </person-group>
            <article-title>Efficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-na&#x000ef;ve HIV-1-infected patients: week-192 overall and subgroup analyses from STARTMRK.</article-title>
            <source>HIV Clin Trials</source>
            <year>2012</year>
            <season>Jul-Aug</season>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>228</fpage>
            <page-range>228-32</page-range>
            <pub-id pub-id-type="pmid">22849964</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Green</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gibb</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Pillay</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Candeias</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Castelli-Gattinara</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Compagnucci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Della Negra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>de Rossi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Feiterna-Sperling</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Giaquinto</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Harper</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Saidi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wintergerst</surname>
                <given-names>U</given-names>
              </name>
              <collab>Paediatric European Network for the Treatment of AIDS (PENTA)</collab>
            </person-group>
            <article-title>Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children.</article-title>
            <source>AIDS</source>
            <year>2007</year>
            <month>May</month>
            <day>11</day>
            <volume>21</volume>
            <issue>8</issue>
            <fpage>947</fpage>
            <page-range>947-55</page-range>
            <pub-id pub-id-type="pmid">17457088</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sax</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Tierney</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Collier</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Fischl</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Mollan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Peeples</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Godfrey</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jahed</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Katzenstein</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Farajallah</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rooney</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Ha</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Woodward</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Koletar</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Geiseler</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Daar</surname>
                <given-names>ES</given-names>
              </name>
              <collab>AIDS Clinical Trials Group Study A5202 Team</collab>
            </person-group>
            <article-title>Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.</article-title>
            <source>N Engl J Med</source>
            <year>2009</year>
            <month>Dec</month>
            <day>03</day>
            <volume>361</volume>
            <issue>23</issue>
            <fpage>2230</fpage>
            <page-range>2230-40</page-range>
            <pub-id pub-id-type="pmid">19952143</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>KY</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fine</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bellos</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sloan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lackey</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Sutherland-Phillips</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Vavro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Yau</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wannamaker</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shaefer</surname>
                <given-names>MS</given-names>
              </name>
              <collab>HEAT Study Team</collab>
            </person-group>
            <article-title>Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment.</article-title>
            <source>AIDS</source>
            <year>2009</year>
            <month>Jul</month>
            <day>31</day>
            <volume>23</volume>
            <issue>12</issue>
            <fpage>1547</fpage>
            <page-range>1547-56</page-range>
            <pub-id pub-id-type="pmid">19542866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <collab>Paediatric European Network for Treatment of AIDS (PENTA)</collab>
            <article-title>Comparison of dual nucleoside-analogue reverse-transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who have not previously been treated: the PENTA 5 randomised trial.</article-title>
            <source>Lancet</source>
            <year>2002</year>
            <month>Mar</month>
            <day>02</day>
            <volume>359</volume>
            <issue>9308</issue>
            <fpage>733</fpage>
            <page-range>733-40</page-range>
            <pub-id pub-id-type="pmid">11888583</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <collab>Committee on Pediatric Aids</collab>
            <article-title>Infant feeding and transmission of human immunodeficiency virus in the United States.</article-title>
            <source>Pediatrics</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>131</volume>
            <issue>2</issue>
            <fpage>391</fpage>
            <page-range>391-6</page-range>
            <pub-id pub-id-type="pmid">23359577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>King</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Kourtis</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Persaud</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ziemniak</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hudgens</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Tegha</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chasela</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Jamieson</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>van der Horst</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Delayed HIV detection among infants exposed to postnatal antiretroviral prophylaxis during breastfeeding.</article-title>
            <source>AIDS</source>
            <year>2015</year>
            <month>Sep</month>
            <day>24</day>
            <volume>29</volume>
            <issue>15</issue>
            <fpage>1953</fpage>
            <page-range>1953-61</page-range>
            <pub-id pub-id-type="pmid">26153671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gaur</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Freimanis-Hance</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dominguez</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Menezes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mussi-Pinhata</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Peixoto</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Alarcon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Coelho</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Read</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Knowledge and practice of prechewing/prewarming food by HIV-infected women.</article-title>
            <source>Pediatrics</source>
            <year>2011</year>
            <month>May</month>
            <volume>127</volume>
            <issue>5</issue>
            <fpage>e1206</fpage>
            <page-range>e1206-11</page-range>
            <pub-id pub-id-type="pmid">21482608</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <collab>Centers for Disease Control and Prevention (CDC)</collab>
            <article-title>Premastication of food by caregivers of HIV-exposed children--nine U.S. sites, 2009-2010.</article-title>
            <source>MMWR Morb Mortal Wkly Rep</source>
            <year>2011</year>
            <month>Mar</month>
            <day>11</day>
            <volume>60</volume>
            <issue>9</issue>
            <fpage>273</fpage>
            <page-range>273-5</page-range>
            <pub-id pub-id-type="pmid">21389930</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22930.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hafeez</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Salami</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Alvarado</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maldonado</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Purswani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hagmann</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Infant feeding practice of premastication: an anonymous survey among human immunodeficiency virus-infected mothers.</article-title>
            <source>Arch Pediatr Adolesc Med</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>165</volume>
            <issue>1</issue>
            <fpage>92</fpage>
            <page-range>92-3</page-range>
            <pub-id pub-id-type="pmid">21199989</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
